1α,25‐Dihydroxyvitamin D3modulates human adipocyte metabolism via nongenomic action
Open Access
- 15 October 2001
- journal article
- fj express-summaries
- Published by Wiley in The FASEB Journal
- Vol. 15 (14) , 1-15
- https://doi.org/10.1096/fj.01-0584fje
Abstract
We reported recently that suppression of the renal lα,25-dihyroxyvitamin D3 (lα,25-(OH)2-D3) production in aP2-agouti transgenic mice by increasing dietary calcium decreases adipocyte intracellular C...Keywords
This publication has 38 references indexed in Scilit:
- Calcium Intake and Body WeightJournal of Clinical Endocrinology & Metabolism, 2000
- Receptors for 1α,25(OH)2D3: Past, Present, and FutureJournal of Bone and Mineral Research, 1998
- Identification of a Membrane Receptor for 1,25-Dihydroxyvitamin D3 Which Mediates Rapid Activation of Protein Kinase CJournal of Bone and Mineral Research, 1998
- Oral Calcium Supplementation Reduces Intraplatelet Free Calcium Concentration and Insulin Resistance in Essential Hypertensive PatientsHypertension, 1997
- 1β, 25(OH)2-vitamin D3 is an antagonist of 1α,25(OH)2-vitamin D3 stimulated transcaltachia (The rapid hormonal stimulation of intestinal calcium transport)Biochemical and Biophysical Research Communications, 1992
- 1α,25-Dihydroxyvitamin D3 rapidly increases cytosolic calcium in clonal rat osteosarcoma cells lacking the vitamin D ReceptorJournal of Bone and Mineral Research, 1991
- Possible role of cytosolic free calcium concentrations in mediating insulin resistance of obesity and hyperinsulinemia.Journal of Clinical Investigation, 1988
- Evidence of a probable role for 25-hydroxyvitamin D in the regulation of human calcium metabolismJournal of Bone and Mineral Research, 1988
- Evidence that obesity does not influence the vitamin D-endocrine system in blacksJournal of Bone and Mineral Research, 1986
- Evidence for alteration of the vitamin D-endocrine system in obese subjects.Journal of Clinical Investigation, 1985